Form 8-K - Current report:
SEC Accession No. 0001104659-25-033871
Filing Date
2025-04-11
Accepted
2025-04-10 21:21:57
Documents
13
Period of Report
2025-04-10
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2512082d1_8k.htm   iXBRL 8-K 95240
  Complete submission text file 0001104659-25-033871.txt   283310

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA enfn-20250410.xsd EX-101.SCH 3014
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE enfn-20250410_lab.xml EX-101.LAB 34239
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE enfn-20250410_pre.xml EX-101.PRE 22358
15 EXTRACTED XBRL INSTANCE DOCUMENT tm2512082d1_8k_htm.xml XML 3801
Mailing Address 125 SOUTH CLARK STREET, SUITE 750 CHICAGO IL 60603
Business Address 125 SOUTH CLARK STREET, SUITE 750 CHICAGO IL 60603 (312) 253-9800
Enfusion, Inc. (Filer) CIK: 0001868912 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40949 | Film No.: 25829625
SIC: 7372 Services-Prepackaged Software
(CF Office: 06 Technology)